Accelerated approval history
Accelerated approval history
| Studies reviewed | ||||
| Product | Indication | Approved | Company | (total patients) (A) |
| Arimidex anastrozole | Adjuvant treatment for hormone receptor-positive early breast cancer | 9/5/02 | AstraZeneca | 1 (9,366) |
| Bexxar tositumomab |
